Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

2 results

  • Active substance : valaciclovir
  • Active substance : valganciclovir
Filter
Topic
  • Diagnostic and therapeutic techniques (2)
  • Plus ...
    • Diagnostic techniques and procedures (2)
    • Plus ...
      • Biology (laboratory tests) (2)
  • Diseases and conditions (2)
  • Plus ...
    • Infectious diseases (2)
    • Plus ...
      • Virus diseases (2)
      • Sexually transmitted diseases (1)
    • Pregnancy and reproduction (1)
    • Plus ...
      • Pregnancy (1)
  • Population groups (1)
  • Plus ...
    • Paediatrics (1)
Content type
  • Drugs, devices and medical acts (2)
  • Plus ...
    • Health technology assessment (2)
Language
  • Français (2)
Active substance
  • aciclovir (1)
  • ganciclovir (2)
  • valaciclovir (2)
  • valganciclovir (2)
 More filter Other Filter Icon
Search Export

Drugs, devices and medical acts - 2 results

  • Evaluation of gene amplification for the diagnosis of Herpesviridae infections (cytomegalovirus, herpes simplex virus and varicella-zoster virus) in people living with HIV - INAHTA Brief

    Health technology assessment - Posted on 29/1/2016
    Download document
    Add to my selection

  • Diagnosis of congenital cytomegalovirus infection through serology testing and/or viral genome detection - INAHTA Brief

    Health technology assessment - Posted on 19/11/2015
    Download document
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
U4mZuP2sJW5D5yEb